Samsung Introduces its First 5G-Integrated Mobile Processor, the Exynos 980
Samsung Electronics Co., Ltd., a world leader in advanced semiconductor technology, today announced its latest mobile processor, the Exynos 980, which combines the best-in-class connectivity with an integrated 5G modem and intelligent processing performance in a single chip.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190904005389/en/
Samsung Introduces its First 5G-Integrated Mobile Processor, the Exynos 980 (Graphic: Business Wire)
“With the introduction of our 5G modem last year, Samsung has been driving in the 5G revolution and paved the way towards the next step in mobility,” said Ben Hur, vice president of System LSI marketing at Samsung Electronics. “With the 5G-integrated Exynos 980, Samsung is pushing to make 5G more accessible to a wider range of users and continues to lead innovation in the mobile 5G market.”
Based on advanced 8-nanometer (nm) FinFET process technology, the Exynos 980 is Samsung’s first artificial intelligence (AI) mobile processor with an integrated 5G modem. Rather than being coupled with a separate 5G modem, the 5G-enabled Exynos 980 not only helps reduce power consumption but also increase the space efficiency within a device. The new mobile processor’s powerful modem supports 5G to 2G networks, providing a fast gigabit downlink speed in 4G LTE and up to 2.55-gigabits per seconds (Gbps) in sub-6-gigahertz (GHz) 5G. The modem also supports E-UTRA-NR Dual Connectivity (EN-DC), which combines 2CC LTE and 5G connectivity to maximize mobile downlink speed of up to 3.55Gbps. In addition, the processor supports a new Wi-Fi 6 standard, IEEE 802.11ax, that provides faster speed and greater stability for seamless online gaming and smooth high-resolution video streaming over Wi-Fi networks.
With powerful CPU and GPU on board, the Exynos 980 can run multiple apps, intricate UX designs and high-resolution graphic games effortlessly. Packing two of the latest high-performance Cortex-A77 CPU cores and six efficient Cortex-A55 cores, the Exynos 980 can deliver the fast and complex computing power required in the 5G era. For realistic gaming and immersive mixed-reality experiences, the processor also comes with the top-of-the-line Mali-G76 GPU.
The neural processing unit (NPU) features elevated performances of up to 2.7 times compared to its predecessor and is built into the Exynos 980 to provide new levels of on-device intelligence. With the NPU readily available on-chip, AI tasks are processed right from the device rather than off-loaded to a server, thereby providing better data privacy and security. The NPU adds enhancements to applications such as secure user authentication, content filtering, mixed reality, intelligent camera, and more.
For advanced photography, the Exynos 980 delivers compelling camera performances with resolution support for up to 108-megapixels (Mp). The advanced image signal processor (ISP) supports up to five individual sensors and is able to process three concurrently for richer multi-camera experiences. Along with the NPU, the AI-powered camera is able to detect and understand scenes or objects, according to which the camera will then make optimal adjustments to its settings.
For an immersive multimedia experience, the Exynos 980’s multi-format codec (MFC) supports encoding and decoding of 4K UHD video at 120 frames per second (fps). HDR10+ support with dynamic mapping also offers more detailed and illuminant colors in video content.
The Exynos 980 is expected to begin mass production by the end of this year.
For more information about Samsung’s Exynos products, please visit http://www.samsung.com/exynos.
# # #
About Samsung Electronics Co., Ltd.
Samsung inspires the world and shapes the future with transformative ideas and technologies. The company is redefining the worlds of TVs, smartphones, wearable devices, tablets, digital appliances, network systems, and memory, system LSI, foundry and LED solutions. For the latest news, please visit the Samsung Newsroom at http://news.samsung.com.
Samsung Semiconductor Europe GmbH
About Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
GSMA Recognizes Turkcell and P.I. Works for the Value of AI Based Network Automation27.1.2020 07:00:00 CET | Press release
Turkcell and P.I. Works have been recognized by GSMA Future Networks Programme for achieving exceptional efficiency gains in network operations and ensuring superior customer experience. P.I. Works and Turkcell have successfully shown that the AI based, service aware network automation delivered stronger improvements as compared to conventional automation solutions. The details of the deployed solutions and their benefits are provided in a joint white paper authored by GSMA, Turkcell and P.I. Works under GSMA’s Future Networks Programme. To read the white paper please visit: https://www.gsma.com/futurenetworks/wiki/case-study-ai-use-cases-in-service-assurance/ GSMA Future Networks Programme intends to help operators share best practices and discover new opportunities that will enable them to reduce operational and capital expenditures. Given the success of the project, GSMA invited Turkcell and P.I. Works to join the program and provide insights for the AI-based, Service Aware Automate
Phase 2 DESTINY-Gastric01 Trial of DS-8201 Versus Chemotherapy Met Primary Endpoint27.1.2020 07:00:00 CET | Press release
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca today announced positive topline results from the pivotal phase 2 DESTINY-Gastric01 trial of DS-8201, a HER2 directed antibody drug conjugate (ADC), in patients with HER2 positive unresectable or metastatic gastric or gastroesophageal junction cancer that had progressed following two or more treatment regimens including trastuzumab and chemotherapy. The trial met its primary endpoint, achieving a statistically significant and clinically meaningful improvement in objective response rate (ORR), as assessed by an independent review committee, in patients treated with DS-8201 versus investigator’s choice of chemotherapy (irinotecan or paclitaxel monotherapy). DS-8201 also showed a statistically significant and clinically meaningful improvement in overall survival (OS), a key secondary endpoint. The safety profile observed for DS-8201 in DESTINY-Gastric01 was consistent with previous clinical trials. These results c
Test Company Announces Third Quarter Earnings24.1.2020 17:36:00 CET | Press release
Test Company of San Francisco (NYSE:TEST) (TSX:TEST) (BSE:TEST) (LSE:TEST) issued their third quarter earnings statement today. Test Company reported diluted earnings per share of $0.11 in the third quarter of 2018, down by 1.1% from $1.01 in the third quarter of 2017, principally due to a $0.08 tax benefit recorded in 2017. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190807005678/en/ Test Photo with Caption - Violin - please visit www.businesswire.com for more details For XHTML support documents from Business Wire please view our tools site. Conference Call A conference call, hosted by John Doe, Chief Financial Officer, with members of the investment community and news media will be webcast at 9:00 a.m. Eastern Time on December 31, 2011. Access is available at www.businesswire.com. 2018 Full-Year Forecast Test Company increases its forecast for 2018 full-year reported diluted earnings per share to a range of $2.20 to $2.
HighRes Biosolutions and Novo Nordisk partner to transform drug discovery in automated Lab of the Future24.1.2020 14:00:00 CET | Press release
HighRes Biosolutions and Novo Nordisk A/S today announced that they will collaborate to design a state-of-the-art robotic platform for high-throughput biologics engineering and characterisation. The integration of a multi-system robotics platform with sophisticated software control architecture will enable a digital transformation and accelerated discovery for Novo Nordisk’s peptide and large molecule therapeutics research. “In order to maintain our leadership within biologics engineering we are investing in a fully automated and digital design platform. This investment is linked to our build-up in AI and advanced analytics and demonstrates Novo Nordisk’s commitment as a world leading biologics research company,” said Lars Fogh Iversen, senior vice president, Global Research Technologies, Novo Nordisk. The platform will comprise several highly automated and integrated cells for production, characterisation and functional analysis of thousands of biologic compounds every month. Its scop
Conquest Invests in 5 Greenfield Onshore Wind Parks Totalizing 43MW in the Flanders Region24.1.2020 12:37:00 CET | Press release
Conquest, acting through the Conquest Sustainable Infrastructure fund, announced the transaction was closed after an exclusive agreement had been reached with ENGIE Electrabel. Conquest acquires 51% of a portfolio expected to provide 111 GWh per annum of renewable power representing the annual electricity consumption of about 32,000 Belgian homes from early 2021 onwards. The projects benefit from 15 to 20-year green certificates local remuneration schemes, and thus generate yearly secured revenues. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200124005221/en/ Credit: Electrabel While the energy and digital transitions continue to drive the infrastructure sector, Conquest keeps building its diversified sustainable real asset portfolio in Western European markets. The success lies in years of collaboration and long-lasting partnerships with fellow industry experts who can notably facilitate access to new growth opportunities
Fluence Expands EMEA Footprint with Horticulture Partners in Papenburg, Germany24.1.2020 11:00:00 CET | Press release
Fluence by OSRAM (Fluence), a leading global provider of energy-efficient LED lighting solutions for commercial cannabis and agriculture production, announced today it is expanding its presence in the Emsland region of Germany through partnerships with growers and other horticulture specialists operating out of Papenburg. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200124005109/en/ Friedrich Schulz’s 5.5 hectare farm—which grows herbs year-round in addition to lettuce, peppers and chives—utilizing VYPR 2p fixtures. (Photo: Business Wire) Given Papenburg’s decades-long history of attracting horticulture experts, Fluence’s innovative lighting solutions for horticulture are a natural fit for the region’s tomato, cucumber, leafy greens and herb growers. Forging connections with Papenburg’s horticultural leaders Elektro Evers, an engineering firm specializing in greenhouse technology, is Fluence’s exclusive systems integrator